Variables |
Progressors
n = 1814 (%) |
Non-progressors
n = 1107 (%) |
PR (95 CI%) |
P Value |
Age group at diagnosis, years |
|
|
|
|
<20 |
69 (3.8) |
48 (4.3) |
1 |
|
20-29 |
415(22.9) |
278( 25.1) |
1.1 (0.9-1.2) |
|
30-39 |
659 (36.3) |
356 (32.2) |
1.1 (1.0-1.2) |
|
40-49 |
496 (27.3) |
267 (24.1) |
0.9 (0.7-1.0) |
|
50-59 |
140 (7.7) |
131 (11.8) |
0.9 (0.7-1.3) |
|
≥60 |
35 (1.9) |
27 (2.4) |
1.0 (0.8-1.3) |
|
Diagnosis facility |
|
|
|
|
Public |
420 (23.2) |
305 (27.6) |
1 |
|
Private |
1365 (75.3) |
698 (63.1) |
1.1 (1.1-1.3) |
0.0172 |
Federal |
8 (0.4) |
6 (0.5) |
1.0 (0.5-2.0) |
|
Unknown |
21 (1.2) |
98 (8.9) |
0.3 (0.1-1.4) |
|
Exposure category |
|
|
|
|
Heterosexual contact only |
874(48.2) |
534 (48.2) |
1 |
|
IDU only |
302 (16.7) |
60 (5.4) |
1.3 (1.2-1.5) |
<0.0001 |
IDU and heterosexual contact |
285 (15.7) |
125 (11.3) |
1.1 (1.0-1.3) |
|
Other |
12 (0.7) |
1 (0.1) |
1.5 (0.8-2.6) |
|
Risk not identified |
341 (18.8) |
387 (35.0) |
0.8 (0.7-0.9) |
<0.0001 |
Insurance |
|
|
|
|
Medicaid |
688 (37.9) |
251 (22.7) |
0.9 (0.7-1.0) |
|
Private |
372 (20.5) |
114 (10.3) |
0.9 (0.8-1.1) |
|
No coverage |
162 (8.9) |
29 (2.6) |
1 |
|
Other |
240 (13.2) |
163 (14.7) |
0.7 (0.6-0.9) |
0.0005 |
Clinical trials/Government |
12 (0.7) |
62 (5.6) |
0.2 (0.1-0.3) |
<0.0001 |
Unknown |
340 (18.7) |
488 (44.1) |
0.6 (0.5-0.8) |
<0.0001 |
DC ward of residence at diagnosis |
|
|
|
|
1 |
189 (10.4) |
108 (9.8) |
1.0 (0.5-2.1) |
|
2 |
97(5.4) |
47 (4.2) |
1.1 (0.5-2.3) |
|
3 |
8 (0.4) |
5 (0.5) |
1 |
|
4 |
195 (10.8) |
110 (9.9) |
1.0 (0.5-2.1) |
|
5 |
279 (15.4) |
205 (18.5) |
0.9 (0.5-1.9) |
|
6 |
256 (14.1) |
139 (12.6) |
1.1 (0.5-2.1) |
|
7 |
376 (20.7) |
223 (20.1) |
1.0 (0.5-1.9) |
|
8 |
414 (22.8) |
270 (24.4) |
1.0 (0.5-2.0) |
|
Most recent CD4 count (cells/µl)
<200
≥200
Missing |
1038(57.2
719 (39.6)
57 (3.1) |
0 (0.0)
860 (77.7)
247 (22.3) |
2.2 (2.0-2.4)
1
NA |
<0.0001 |
Most recent viral load (copies/ml)
≤400
>400
Missing |
243 (13.4)
600 (33.1)
971 (53.5) |
217 (19.6)
358 (32.3)
532 (48.1) |
1
1.2 (1.1-1.4)
NA |
0.0252 |
Treatment/service referrals |
|
|
|
|
Has this patient been informed of HIV infection? |
|
|
|
|
Yes |
1684(92.8) |
963 (87.0) |
1.3 (1.1-1.6) |
|
No |
39 (2.2) |
46 (4.1) |
1 |
|
Missing |
91 (5.0) |
98 (8.9) |
NA |
|
This patient is receiving or has been referred for: |
|
|
|
|
HIV related medical services
Yes
No
Missing |
1530 (84.3)
201 (15.7)
83 (4.6) |
694 (62.7)
413 (37.3)
43 (3.9) |
1.6 (1.4-1.9)
1
NA |
<0.0001 |
Substance abuse treatment services
Yes
No
Missing |
393 (21.7)
1226 (67.6)
195 (10.7) |
121 (10.9)
874 (78.9)
112 (10.2) |
1.3 (1.2-1.4)
1
NA |
<0.0001 |
This patient received or is receiving: |
|
|
|
|
Anti-retroviral drugs
Yes
No
Missing |
1256 (69.2)
327 (18.0)
231 (12.7) |
496 (44.8)
385 (34.8)
226 (20.4) |
1.5 (1.3-1.7)
1 |
<0.0001 |
PCP prophylaxis
Yes
No
Missing |
832 (45.9)
719 (39.6)
263 (14.5) |
110 (9.9)
732 (66.1)
265 (23.9) |
1.8 (1.6-2.0)
1 |
<0.0001 |
Percent of African American residents living below the federal poverty line |
|
|
|
|
≤30% |
1046 (57.7) |
615 (55.6) |
1.0 (0.9-1.1) |
|
>30% |
768 (42.3) |
492 (44.4) |
1 |
|
Highest education level |
|
|
|
|
High school education or lower |
|
|
|
|
≤50% |
296 (16.3) |
165 (14.9) |
1.0 (0.9-1.2) |
|
>50% |
1519 (83.7) |
941 (85.1) |
1 |
|
Some college |
|
|
|
|
≤15% |
401 (22.1) |
236 (21.3) |
1.0 (0.9-1.1) |
|
>15% |
1413 (77.9) |
871 (78.7) |
1 |
|
Associates degree |
|
|
|
|
≤30% |
1771 (97.6) |
1068 (96.5) |
1.2 (0.9-1.6) |
|
>30% |
43 (2.4) |
39 (3.5) |
1 |
|
Bachelor’s degree |
|
|
|
|
≤30% |
1765 (97.3) |
1089 (98.4) |
0.9 (0.6-1.1) |
|
>30% |
49 (2.7) |
18 (1.6) |
1 |
|
Graduate degree |
|
|
|
|
≤15% |
1633 (90.0) |
1006 (90.9) |
1.0 (0.8-1.1) |
|
>15% |
181 (10.0) |
101 (9.1) |
1 |
|
HIV care and treatment facility within census tract |
|
|
|
|
Yes |
893 (49.2) |
534 (48.2) |
1.0 (0.9-1.1) |
|
No |
921 (50.8) |
573 (51.7) |
1 |
|
Single-female household with children |
|
|
|
|
≤15% |
1716(94.6) |
1055 (95.3) |
1 |
|
>15% |
98 (5.4) |
52 (4.7) |
1.1 (0.9-1.3) |
|
Place of residence |
|
|
|
|
Rented |
|
|
|
|
≤50% |
711 (39.2) |
404 (36.5) |
1.0 (1.0-1.1) |
|
> 50% |
1103 (60.8) |
703 (63.5) |
1 |
|
Owned |
|
|
|
|
≤50% |
1539 (84.8) |
935 (84.5) |
1.1 (0.8-1.1) |
|
>50% |
275 (15.2) |
172 (15.5) |
1 |
|